文献速递产科

减少产后阿片类药物使用:一项质量改进项目

Decreasing Opioid Use Postpartum: A Quality Improvement Initiative.
PubMed 文献 · Obstet Gynecol · 2019-01-01

在德克萨斯州中部5家医院开展质量改进项目,采用标准化多模式疼痛管理方案,比较实施前10个月与实施后12个月分娩产妇。阴道分娩者阿片类药物使用风险降低26%(RR 0.74,95%CI 0.68-0.81),剖宫产者降低18%(RR 0.82,95%CI 0.72-0.92);但报告可接受疼痛水平的产妇比例下降。

要点

  • 标准化多模式疼痛管理方案可降低产后阿片类药物使用风险。
  • 阴道分娩者阿片使用风险降低26%,剖宫产者降低18%。
  • 部分产妇报告住院期间疼痛可接受水平下降,需关注疼痛控制。

核心结论

  • 标准化多模式疼痛管理方案降低了德克萨斯州中部大量分娩产妇的阿片类药物使用。
  • 尽管达到功能目标,部分产妇报告住院期间疼痛增加。

研究设计与样本

  • 质量改进项目,纳入5家医院实施前10个月分娩的6892名产妇与实施后12个月分娩的7527名产妇。
  • 排除既往物质使用障碍或复杂分娩者,分析按阴道分娩与剖宫产分层。

主要发现

  • 阴道分娩组阿片类药物使用风险降低26%(RR 0.74;95%CI 0.68-0.81)。
  • 剖宫产组阿片类药物使用风险降低18%(RR 0.82;95%CI 0.72-0.92)。
  • 接受阿片类药物的产妇中,阴道分娩组平均吗啡毫克当量(MME)使用减少21%(RR 0.79;95%CI 0.70-0.88),剖宫产组减少54%(RR 0.46;95%CI 0.35-0.61)。
  • 报告可接受疼痛水平的产妇比例下降:阴道分娩组从82%降至69%(P<.01),剖宫产组从82%降至74%(P<.01)。
  • 实施后剖宫产组中,产妇报告在医院消费者医疗提供者与系统评估问卷中疼痛得到良好控制的可能性更低(82% vs 62%,P<.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the effects of an inpatient initiative to decrease opioid use among women admitted to labor and delivery. METHODS: We created a multimodal pain power plan with standard therapeutic postpartum activity goals rather than pain goals, tiered order sets with scheduled administration of nonsteroidal antiinflammatory drugs (NSAIDs), and embedded changes into the electronic health record. Before the multimodal pain power plan launch, pain was assessed on a 10-point scale; women received NSAIDs for pain levels of 3 or less and opioids for pain levels higher than 3. For this analysis, we included women who delivered at 5 hospitals in the 10 months before and 12 months after the multimodal pain power plan launch. Women with prior substance use disorder or complicated deliveries were excluded and we stratified analyses into women who delivered vaginally compared with by cesarean. Opioid use was converted to morphine milligram equivalent (MME). Women rated pain control in 24-hour blocks using individually ascertained cutoffs. A multivariable regression analysis was performed, and adjusted odds ratios are reported. RESULTS: We compared the 6,892 women who delivered 10 months before the pain power plan launch to the 7,527 who delivered in the 12 months after the launch. The mean cohort age was 29.6±6.0 years; the majority (75%) were white. Risk of opioid use decreased by 26% among women who delivered vaginally (risk ratio [RR] 0.74; 95% CI [0.68, 0.81]) and 18% among women who delivered by cesarean (RR 0.82; 95% CI [0.72, 0.92]). Among women who received opioids, mean MME use decreased 21% (RR 0.79; 95% CI [0.70, 0.88]) and 54% (RR 0.46; 95% CI [0.35, 0.61]) in the vaginal and cesarean delivery groups, respectively. Fewer women reported acceptable pain levels, with decreases of 82-69% (P<.01) and 82-74% (P<.01) in the vaginal and cesarean delivery groups, respectively. Within the postlaunch cesarean delivery group, women also reported that they were less likely to have their pain well controlled on the Hospital Consumer Assessment of Healthcare Providers and Systems questionnaires (82% vs 62%, P <.01). CONCLUSION: A standardized multimodal pain power plan reduced opioid use among a large cohort of women admitted to labor and delivery in Central Texas. Despite meeting functional goals, some women reported increased pain during their hospital stay.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Rogers RG, Nix M, Chipman Z, et al. Decreasing Opioid Use Postpartum: A Quality Improvement Initiative. Obstet Gynecol. 2019. PMID: 31599842. doi:10.1097/AOG.0000000000003512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。